Aspirin-induced increase in intestinal paracellular permeability does not affect the levels of LPS in venous blood of healthy women

Innate Immunity

Volumn 21, Issue 5, 2015, Pages 537-545

  Gnauck, Anne ^a   Lentle, Roger G ^a   Kruger, Marlena C ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

Aspirin; intestinal permeability; lactulose; lipopolysaccharide; mannitol

Indexed keywords

ACETYLSALICYLIC ACID; LACTULOSE; LIPOPOLYSACCHARIDE; MANNITOL; WATER; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BLOOD LEVEL; BODY FAT; BODY HEIGHT; BODY MASS; CARBOHYDRATE TRANSPORT; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FAT CONTENT; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INTESTINAL EXCRETION; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSIT TIME; NORMAL HUMAN; SMALL INTESTINE MUCOSA; BLOOD; BODY COMPOSITION; DOSE RESPONSE; DRUG EFFECTS; GASTROINTESTINAL TRANSIT; INTESTINE; INTESTINE ABSORPTION; INTESTINE MUCOSA; LIPID DIET; METABOLISM; OBESITY; PERMEABILITY; PHYSIOLOGY; URINE; YOUNG ADULT;

NEGIBACTERIA;

ADIPOSITY; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BODY COMPOSITION; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL TRANSIT; HEALTHY VOLUNTEERS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINES; LACTULOSE; LIPOPOLYSACCHARIDES; MANNITOL; PERMEABILITY; YOUNG ADULT;

EID: 84930401789     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425914557101     Document Type: Article

References (35)

1. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007; 56: 1761-1772
2. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007; 50: 2374-2383
3. Lassenius MI, Pietiläinen KH, Kaartinen K, et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care. 2011; 34: 1809-1815
4. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007; 86: 1286-1292
5. Ghanim H, Abuaysheh S, Sia CL, et al. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care. 2009; 32: 2281-2287
6. Deopurkar R, Ghanim H, Friedman J, et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care. 2010; 33: 991-997
7. Laugerette F, Vors C, Géloën A, et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem. 2011; 22: 53-59
8. Clemente-Postigo M, Queipo-Ortuño MI, Murri M, et al. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res. 2012; 53: 973-978
9. Ghanim H, Sia CL, Upadhyay M, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr. 2010; 91: 940-949
10. Ghanim H, Sia CL, Korzeniewski K, et al. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab. 2011; 96: 1409-1414
11. Ghoshal S, Witta J, Zhong J, et al. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 2009; 50: 90-97
12. Kvietys PR, Specian RD, Grisham MB, Tso P. Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Am J Physiol. 1991; 261: G384 - G391
13. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009; 58: 1091-1103
14. Jenkins RT, Bell RA. Molecular radii of probes used in studies of intestinal permeability. Gut. 1987; 28: 110-111
15. Sequeira IR, Lentle RG, Kruger MC, Hurst RD. The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability. Neurogastroenterol Motil. 2012; 24: e401 - e411
16. Sequeira IR, Lentle RG, Kruger MC, Hurst RD. Differential trafficking of saccharidic probes following aspirin in clinical tests of intestinal permeability in young healthy women. Clin Exp Pharmacol Physiol. 2014; 41: 107-117
17. Smecuol E, Pinto Sanchez MI, Suarez A, et al. Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol. 2009; 7: 524-529
18. Nishida U, Kato M, Nishida M, et al. Evaluation of gastrointestinal injury and blood flow of small bowel during low-dose aspirin administration. J Clin Biochem Nutr. 2011; 48: 245-250
19. Mizukami K, Murakami K, Abe T, et al. Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol. 2011; 17: 5117-5122
20. Gutsmann T, Howe J, Zähringer U, et al. Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells. Innate Immun. 2010; 16: 39-47
21. Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med. 1987; 28: 1204-1207
22. Bennink R, Peeters M, Van den Maegdenbergh V, et al. Comparison of total and compartmental gastric emptying and antral motility between healthy men and women. Eur J Nucl Med. 1998; 25: 1293-1299
23. Teixeira TF, Souza NC, Chiarello PG, et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr. 2012; 31: 735-740
24. McCrory MA, Molé PA, Gomez TD, et al. Body composition by air-displacement plethysmography by using predicted and measured thoracic gas volumes. J Appl Physiol. 1998; 84: 1475-1479
25. Altmann DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983; 32: 307-17
26. Amar J, Burcelin R, Ruidavets JB, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008; 87: 1219-1223
27. Miller MA, McTernan PG, Harte AL, et al. Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis. 2009; 203: 494-502
28. Lambert GP, Schmidt A, Schwarzkopf K, Lanspa S. Effect of aspirin dose on gastrointestinal permeability. Int J Sports Med. 2012; 33: 421-425
29. Jacob AI, Goldberg PK, Bloom N, et al. Endotoxin and bacteria in portal blood. Gastroenterology. 1977; 72: 1268-1270
30. Brun P, Castagliuolo I, Di Leo V, et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007; 292: g518 - g525
31. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology. 1988; 8: 232-236
32. Volynets V, Küper MA, Strahl S, et al. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci. 2012; 57: 1932-1941
33. Chakraborty S, Zawieja S, Wang W, et al. Lymphatic system: a vital link between metabolic syndrome and inflammation. Ann N Y Acad Sci. 2010; 1207: E94 - E102
34. Iqbal J, Hussain MM. Intestinal lipid absorption. Am J Physiol Endocrinol Metab. 2009; 296: E1183 - E1194
35. Enomoto N, Yamashina S, Schemmer P, et al. Estriol sensitizes rat Kupffer cells via gut-derived endotoxin. Am J Physiol. 1999; 277: G671 - G677